2. Signaling Pathways
  3. Others
  4. Drug Derivative

Drug Derivative

Drug derivative

Drug derivatives are derived from parent compounds. They replace or add atoms and groups through chemical reactions to optimize the various properties of the parent compound and reduce side effects. The application of drug derivatives provides a diverse compound library for drug research and development and accelerates the discovery of new drugs. For example, urea derivatives Glibenclamide can prolong the blood sugar-lowering effect of anti-diabetic drugs.

Drug Derivative Related Products (1342):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-19300A
    PNU-142731A
    PNU-142731A is an active compound.
    PNU-142731A
  • HY-117439
    (R)-Norverapamil
    (R)-Norverapamil is an active compound.
    (R)-Norverapamil
  • HY-124168
    PF-244
    PF-244 is an active compound.
    PF-244
  • HY-113812
    ZK110841
    ZK110841 is an active compound.
    ZK110841
  • HY-133603
    4,5-Dichloroveratrole
    4,5-Dichloroveratrole is a chlorinated product formed by reaction of Veratryl alcohol (VE; HY-107858) with chlorine dioxide solution.
    4,5-Dichloroveratrole
  • HY-W072274
    (S)-Desoxy-D2PM hydrochloride
    (S)-Desoxy-D2PM ((S)-2-Diphenylmethylpyrrolidine) hydrochloride is a neuroactive compound.
    (S)-Desoxy-D2PM hydrochloride
  • HY-136891
    AHR-16303B
    AHR-16303B is an active compound.
    AHR-16303B
  • HY-105414
    Esterbut-3
    Esterbut-3 is a potent anticancer agent. Esterbut-3 inhibits cell proliferation. Esterbut-3 decreases the antigen expression of 115D8, 140C1 and increases the antigen expression of 123C3. Esterbut-3 induces cell cycle arrest at G0/G1 phase.
    Esterbut-3
  • HY-149686
    WAY-299765
    		≥98.0%
    WAY-299765 is an active molecule.
    WAY-299765
  • HY-115963
    Anticancer agent 38
    Anticancer agent 38 (compound 19), a sulfonylurea derivative, is a potent anticancer agent. Anticancer agent 38 inhibits A431 cell growth with an IC50 of 5.2 µg/mL.
    Anticancer agent 38
  • HY-146025
    Antitumor agent-F10
    Antitumor agent-F10 (Compound F10) is a camptothecin derivative. Antitumor agent-F10 is an orally–bioavailable and potent antitumor agent. Antitumor agent-F10 displays lower acute toxicity than SN-38 does and the solubility of F10 reached 9.86 μg/mL.
    Antitumor agent-F10
  • HY-P10063
    Cionin
    Cionin is a disulfotyrosyl hybrid of cholecystokinin and gastrin.
    Cionin
  • HY-111221
    PD 113271
    PD 113271 is an active compound.
    PD 113271
  • HY-149076
    hGAPDH-IN-1
    hGAPDH-IN-1, a 3-bromo-4,5-dihydroisoxazole derivative, is a specific and potent hGAPDH covalent inhibitor. hGAPDH-IN-1 reduces cancer cell growth in different pancreatic cancer cell lines.
    hGAPDH-IN-1
  • HY-145082
    4-Sulfo-N-(4-aminobenzyl)-1,8-naphthalimide potassium
    4-Sulfo-N-(4-aminobenzyl)-1,8-naphthalimide potassium is an inactive 1,8-Naphthalimide derivative. 4-Sulfo-N-(4-aminobenzyl)-1,8-naphthalimide potassium can be used as a negative control for the clathrin inhibitor 3-Sulfo-N-benzyl-1,8-naphthalimide, potassium salt.
    4-Sulfo-N-(4-aminobenzyl)-1,8-naphthalimide potassium
  • HY-121769
    BFE-61
    BFE-61 is an active compound.
    BFE-61
  • HY-W747533
    C8 Ceramine, D-erythro
    C8 Ceramine is an analog of ceramide in which the carbonyl group of the ceramide is replaced by a methylene group. At a concentration of 10 μM, C8 ceramine induces maximal DNA fragmentation in U937 cells after 6 hours of incubation, compared to 12 hours for C8 ceramide.
    C8 Ceramine, D-erythro
  • HY-149684
    WAY-621924
    		≥98.0%
    WAY-621924 is an active molecule.
    WAY-621924
  • HY-106736
    Etilefrine pivalate hydrochloride
    Etilefrine pivalate hydrochloride is an orally active compound and can be used for study of migraine headaches.
    Etilefrine pivalate hydrochloride
  • HY-149682
    WAY-659873
    		≥98.0%
    WAY-659873 is an active molecule.
    WAY-659873